Michael Diamond

93.7k total citations · 32 hit papers
486 papers, 52.0k citations indexed

About

Michael Diamond is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Michael Diamond has authored 486 papers receiving a total of 52.0k indexed citations (citations by other indexed papers that have themselves been cited), including 317 papers in Infectious Diseases, 304 papers in Public Health, Environmental and Occupational Health and 156 papers in Immunology. Recurrent topics in Michael Diamond's work include Mosquito-borne diseases and control (297 papers), Viral Infections and Vectors (230 papers) and Malaria Research and Control (83 papers). Michael Diamond is often cited by papers focused on Mosquito-borne diseases and control (297 papers), Viral Infections and Vectors (230 papers) and Malaria Research and Control (83 papers). Michael Diamond collaborates with scholars based in United States, Czechia and China. Michael Diamond's co-authors include Theodore C. Pierson, Daved H. Fremont, Timothy A. Springer, Helen M. Lazear, Michael Gale, Melanie A. Samuel, Jonathan J. Miner, Michael J. Engle, Mehul S. Suthar and Michael Farzan and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Michael Diamond

475 papers receiving 51.3k citations

Hit Papers

Batf3 Deficiency Reveals a Critical Role fo... 1990 2026 2002 2014 2008 2016 2006 1990 2019 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity
    2008 1.5k citations Kai Hildner, Brian T. Edelson et al. Science profile →
  2. Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
    2016 1.1k citations Michael Diamond, Maxim N. Artyomov et al. profile →
  3. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus
    2006 926 citations Michael Diamond et al. Proceedings of the National Academy of Sciences profile →
  4. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).
    1990 773 citations Michael Diamond et al. profile →
  5. Shared and Distinct Functions of Type I and Type III Interferons
    2019 761 citations Michael Diamond et al. profile →
  6. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia
    2012 734 citations Michael Diamond et al. profile →
  7. Modified mRNA Vaccines Protect against Zika Virus Infection
    2017 731 citations Michael Diamond et al. profile →
  8. A Mouse Model of Zika Virus Pathogenesis
    2016 698 citations Michael Diamond et al. profile →
  9. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
    2020 674 citations Broc T. McCune, Michael Diamond et al. profile →
  10. 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members
    2010 669 citations Stéphane Daffis, Ganes C. Sen et al. profile →
  11. The continued threat of emerging flaviviruses
    2020 667 citations Michael Diamond et al. profile →
  12. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation
    1991 664 citations Michael Diamond et al. profile →
  13. The broad-spectrum antiviral functions of IFIT and IFITM proteins
    2012 646 citations Michael Diamond et al. profile →
  14. Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise
    2016 621 citations Michael Diamond et al. profile →
  15. Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5
    2011 612 citations Michael Diamond et al. profile →
  16. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
    2020 528 citations Natasha M. Kafai, Broc T. McCune et al. profile →
  17. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
    2020 451 citations James Brett Case, Rita E. Chen et al. Science profile →
  18. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
    2021 448 citations Rita E. Chen, Elitza S. Theel et al. profile →
  19. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
    2022 423 citations Daved H. Fremont, Michael Diamond et al. profile →
  20. Immune responses at the maternal-fetal interface
    2019 419 citations Michael Diamond et al. profile →
  21. Zika virus infection damages the testes in mice
    2016 381 citations Suzanne M. Scheaffer, Michael Diamond et al. profile →
  22. Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
    2015 366 citations Timothy J. Nice, Michael Diamond et al. profile →
  23. Innate immunity: the first line of defense against SARS-CoV-2
    2022 366 citations Michael Diamond et al. profile →
  24. Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere
    2016 360 citations Michael Diamond et al. Journal of Virology profile →
  25. West Nile virus infection and immunity
    2013 327 citations Mehul S. Suthar, Michael Diamond et al. profile →
  26. Zika Virus Pathogenesis and Tissue Tropism
    2017 307 citations Michael Diamond et al. profile →
  27. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice
    2016 295 citations Daved H. Fremont, Michael Diamond et al. profile →
  28. The emergence of Zika virus and its new clinical syndromes
    2018 287 citations Michael Diamond et al. profile →
  29. Mxra8 is a receptor for multiple arthritogenic alphaviruses
    2018 265 citations William B. Klimstra, Daved H. Fremont et al. profile →
  30. After the pandemic: perspectives on the future trajectory of COVID-19
    2021 255 citations Michael Diamond, Herbert W. Virgin et al. profile →
  31. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
    2021 215 citations Rita E. Chen, Larissa B. Thackray et al. profile →
  32. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
    2021 183 citations Rita E. Chen, James Brett Case et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Diamond United States 123 27.4k 24.0k 15.7k 10.1k 8.5k 486 52.0k
Charles M. Rice United States 140 16.0k 0.6× 11.4k 0.5× 13.1k 0.8× 16.8k 1.7× 27.4k 3.2× 476 67.0k
Alan Sher United States 122 8.5k 0.3× 6.9k 0.3× 29.2k 1.9× 9.8k 1.0× 16.5k 2.0× 449 57.2k
Alessandro Sette United States 142 17.2k 0.6× 5.5k 0.2× 40.0k 2.5× 29.6k 2.9× 14.2k 1.7× 858 72.2k
Erol Fikrig United States 91 14.9k 0.5× 7.7k 0.3× 8.2k 0.5× 3.5k 0.4× 2.8k 0.3× 418 28.8k
Adrian V. S. Hill United Kingdom 99 10.9k 0.4× 8.9k 0.4× 14.1k 0.9× 7.8k 0.8× 10.8k 1.3× 479 36.5k
Yasmine Belkaid United States 95 4.7k 0.2× 5.2k 0.2× 20.4k 1.3× 10.5k 1.0× 6.0k 0.7× 217 39.8k
Osamu Takeuchi Japan 109 8.7k 0.3× 4.2k 0.2× 55.9k 3.6× 24.1k 2.4× 15.3k 1.8× 352 81.5k
Victor Nizet United States 108 8.5k 0.3× 9.9k 0.4× 11.4k 0.7× 15.3k 1.5× 6.6k 0.8× 564 43.2k
Adolfo Garcı́a-Sastre United States 122 17.8k 0.7× 5.8k 0.2× 24.5k 1.6× 13.0k 1.3× 28.8k 3.4× 641 53.9k
Bjoern Peters United States 82 8.9k 0.3× 3.1k 0.1× 14.0k 0.9× 18.7k 1.8× 5.2k 0.6× 355 32.3k

Countries citing papers authored by Michael Diamond

Since Specialization
Citations

This map shows the geographic impact of Michael Diamond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Diamond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Diamond more than expected).

Fields of papers citing papers by Michael Diamond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Diamond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Diamond. The network helps show where Michael Diamond may publish in the future.

Co-authorship network of co-authors of Michael Diamond

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Diamond. A scholar is included among the top collaborators of Michael Diamond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Diamond. Michael Diamond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wamhoff, Eike‐Christian, Larance Ronsard, Jared Feldman, et al.. (2024). Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds. Nature Communications. 15(1). 795–795. 40 indexed citations
2.
Ying, Baoling, Chieh-Yu Liang, Pritesh Desai, et al.. (2024). Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain. Journal of Virology. 98(9). e0057424–e0057424. 3 indexed citations
3.
Bricker, Traci L., Astha Joshi, Nadia Soudani, et al.. (2024). Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters. Journal of Virology. 98(3). e0120623–e0120623. 4 indexed citations
4.
Zimmerman, Ofer, et al.. (2023). Entry receptors — the gateway to alphavirus infection. Journal of Clinical Investigation. 133(2). 27 indexed citations
5.
Farnsworth, Christopher W, James Brett Case, Karl Hock, et al.. (2021). Assessment of serological assays for identifying high titer convalescent plasma. Transfusion. 61(9). 2658–2667. 10 indexed citations
6.
Tang, Mei San, James Brett Case, Rita E. Chen, et al.. (2020). Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays. Clinical Chemistry. 66(12). 1538–1547. 80 indexed citations
7.
Zhao, Jincun, Rahul Vijay, Jingxian Zhao, et al.. (2016). MAVS Expressed by Hematopoietic Cells Is Critical for Control of West Nile Virus Infection and Pathogenesis. Journal of Virology. 90(16). 7098–7108. 21 indexed citations
8.
Baldridge, Megan T., Timothy J. Nice, Broc T. McCune, et al.. (2014). Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection. Science. 347(6219). 266–269. 324 indexed citations
9.
Hyde, Jennifer, Christina L. Gardner, Taishi Kimura, et al.. (2014). A Viral RNA Structural Element Alters Host Recognition of Nonself RNA. Science. 343(6172). 783–787. 130 indexed citations
10.
Cho, Hyelim, Bimmi Shrestha, Ganes C. Sen, & Michael Diamond. (2013). A Role for Ifit2 in Restricting West Nile Virus Infection in the Brain. Journal of Virology. 87(15). 8363–8371. 62 indexed citations
11.
Samuel, Melanie A., et al.. (2012). Differential Replication of Pathogenic and Nonpathogenic Strains of West Nile Virus within Astrocytes. Journal of Virology. 87(5). 2814–2822. 46 indexed citations
12.
Purtha, Whitney E., Thomas F. Tedder, Syd Johnson, Deepta Bhattacharya, & Michael Diamond. (2011). Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. The Journal of Experimental Medicine. 208(13). 2599–2606. 172 indexed citations
13.
Hildner, Kai, Brian T. Edelson, Whitney E. Purtha, et al.. (2008). Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity. Science. 322(5904). 1097–1100. 1543 indexed citations breakdown →
14.
Daffis, Stéphane, Melanie A. Samuel, Mehul S. Suthar, Michael Gale, & Michael Diamond. (2008). Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection. Journal of Virology. 82(21). 10349–10358. 272 indexed citations
15.
McCandless, Erin E., Bo Zhang, Michael Diamond, & Robyn S. Klein. (2008). CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proceedings of the National Academy of Sciences. 105(32). 11270–11275. 105 indexed citations
16.
Noueiry, Amine, Paul D. Olivo, Urszula Słomczyńska, et al.. (2007). Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection. Journal of Virology. 81(21). 11992–12004. 38 indexed citations
17.
Chung, Kyung Min, M. Kathryn Liszewski, Grant E. Nybakken, et al.. (2006). West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proceedings of the National Academy of Sciences. 103(50). 19111–19116. 195 indexed citations
18.
Diamond, Michael, et al.. (2006). CD4 + T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System. Journal of Virology. 80(24). 12060–12069. 179 indexed citations
19.
Samuel, Melanie A. & Michael Diamond. (2005). Alpha/Beta Interferon Protects against Lethal West Nile Virus Infection by Restricting Cellular Tropism and Enhancing Neuronal Survival. Journal of Virology. 79(21). 13350–13361. 334 indexed citations
20.
Klein, Robyn S., Eugene C. Lin, Bo Zhang, et al.. (2005). Neuronal CXCL10 Directs CD8 + T-Cell Recruitment and Control of West Nile Virus Encephalitis. Journal of Virology. 79(17). 11457–11466. 337 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles M. Rice Breakdown of academic impact, for papers by Alan Sher Breakdown of academic impact, for papers by Alessandro Sette Breakdown of academic impact, for papers by Erol Fikrig Breakdown of academic impact, for papers by Adrian V. S. Hill Breakdown of academic impact, for papers by Yasmine Belkaid Breakdown of academic impact, for papers by Osamu Takeuchi Breakdown of academic impact, for papers by Victor Nizet Breakdown of academic impact, for papers by Adolfo Garcı́a-Sastre Breakdown of academic impact, for papers by Bjoern Peters
Rankless by CCL
2026